As a platform against cancer, I think we’re in a really excellent position to launch the revolution of highly personalized cancer therapies... and powerful new ways to combine therapies. I think it will be key, once they have the resources to look for ways to accelerate the opportunities to do many combination trials and innovative trial structures with cancers and tumors of all types.
I think the FDA is ready for these futuristic trials and NWBO is in exactly the right position to be one of the early pioneers and beneficiaries of such innovation.
Market Data 
Markets 
AI
